Have not posted or read many posts lately. However I'm disappointed in Leo these days. His PRs lack any substance. I received an email back in June that when results are seen it will be PR'd.. Its now 3 months later and all we get is 5th cohort is complete, nothing more. I think they are in their own zone and have no connection with investors these days and its disappointing. The market is not accepting Leo's updates as anything worth investing in and I don't see what will change this short term. I doubt we close this year any higher than we entered the year.
I think management has spread them selves too thin and have dropped the ball with prurisol and Kevetrin and have gone into some kind of big pharma building mode without enough reality checks and the market is suspect.
I still don't get why another bio company did not make a bid for the new company they bought, something seems off and I think there must of been a reason no one else was interested in buying it.
Market Data 
Markets 
AI
